| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Pharmaceuticals
| Eli Lilly is making significant strides in product development, particularly with its innovative weight-loss drugs, which are showing promising efficacy and the potential to compete robustly in the obesity treatment market. The company is also expanding its focus into infectious diseases and vaccine development, reflecting its commitment to addressing diverse healthcare needs. Advancements in gene therapy further underscore Eli Lilly's dedication to healthcare innovation and its expanding product portfolio. Overall, these developments position the company favorably in a competitive landscape. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at 3.5 is extremely bullish. The market sentiment at 1.1 is very bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. LLY is likely to move up since both trend sentiment and market sentiment are positive. The positive sentiment force for sector is at 1.4, and the negative at -0.3 on 2026-05-26. The forces of Sentiment towards Fundamentals (3.5), Stock Price Trend (3.5), Sector Price Trend (1.3), and Option Sentiment (0.8) will drive up the price. The forces of Valuation Sentiment (-0.2), Price Level Sentiment (-0.5), and Market Risk Appetite (-0.9) will drive down the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| LLY | ||||||||||||||
| Date | Attention | Price | StdDev | Price Level | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | 1%(0.3%) | 1066.33 | 4.96% | 89 | 0.06% | 0.98% | 3.5 | -0.1 | 1.1% | 1.1 | Long | 65% | 3.5 | 5.7 |
| 2026-05-25 | 0%(0.1%) | 3.3 | -0.1 | 1 | 2.9 | 7 | ||||||||
| 2026-05-24 | 0%(0.1%) | 3.3 | -0.1 | 0.8 | 1.4 | -1 | ||||||||
| 2026-05-23 | 0%(0.1%) | 3.3 | -0.1 | 0.8 | 1.9 | -1 | ||||||||
| 2026-05-22 | 0%(0.1%) | 1065.64 | 5.16% | 92 | 2.28% | 1.17% | 3.3 | 0.6 | 1.9% | 0.9 | Long | 55% | 2 | 7 |
| 2026-05-21 | 1%(0.1%) | 1041.9 | 5.19% | 86 | 2.33% | 0.67% | 2.1 | 0.6 | 1.2% | 0.4 | Long | 65% | 1.6 | 6.8 |
| 2026-05-20 | 0%(0%) | 1018.14 | 5.11% | 79 | -0.3% | 0.31% | 0.9 | 0.3 | 1.3% | 0.2 | Long | 55% | 0.7 | -0.5 |
| 2026-05-19 | 0%(0%) | 1021.22 | 4.97% | 83 | 3.34% | 0.33% | 1.5 | 0.6 | 1.2% | 0.4 | Long | 65% | 2.5 | 5.5 |
| 2026-05-18 | 0%(0%) | 988.2 | 5% | 70 | -1.64% | 0.2% | 1 | -0.1 | 1% | 0.6 | Wait | 50% | 2.4 | -8 |
| 2026-05-17 | 0%(0%) | 1.9 | -0.1 | 0.8 | 2.6 | -1 | ||||||||
| Long is the preferred trading strategy with 65% chance of being right. Both trend sentiment and hourly trend are very strong. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||
| Analysis | ||
| ● Eli Lilly (LLY) – Equity Research Report Tue. Mar 17, 2026 | ||
| 2026-05-26 17:48:23 Eli Lilly's use of profits from its obesity drug portfolio to fund acquisitions in the vaccine sector shows a strategic diversification of its investment approach. |
| 2026-05-26 17:48:23 The significant financial commitment of Eli Lilly towards acquiring clinical-stage vaccine companies indicates a strong belief in the potential of vaccine development as a future revenue stream. |
| 2026-05-26 17:48:23 Eli Lilly's strategic acquisitions of vaccine developers to enhance its portfolio in infectious disease prevention reflects a proactive approach to addressing public health needs. |
| 2026-05-26 17:01:41 The general recovery observed in the large-cap pharmaceuticals industry contributes to the positive outlook for companies like Eli Lilly amidst its new acquisitions. |
| 2026-05-26 17:01:41 Lilly’s renewed focus on infectious diseases marks a strategic pivot aimed at expanding its impact beyond its traditional specialties of diabetes and obesity. |
| 2026-05-26 17:01:41 Lilly's stock has seen positive movements following the announcement of its acquisition spree, reflecting investor confidence in the company's future direction. |
| 2026-05-26 17:01:41 The company is making strategic acquisitions of biotech firms to enhance its capabilities in infectious disease prevention, indicating a shift in corporate strategy. |
| 2026-05-26 17:01:41 Eli Lilly is focusing on expanding its portfolio into vaccine development through significant acquisitions aimed at addressing infectious diseases. |
| 2026-05-26 11:49:07 Eli Lilly is diversifying its portfolio by looking beyond traditional areas, which can indicate strong leadership and a strategic approach to growth. |
| 2026-05-26 11:49:07 Despite positive study results, Eli Lilly's stock remained relatively unchanged, suggesting investor skepticism or market saturation. |
| 2026-05-26 11:49:07 The article discusses Eli Lilly's progress in gene therapy, highlighting positive results which indicate a promising development in healthcare innovation. |
| 2026-05-26 09:35:43 Lilly's stock remained stable despite significant announcements, reflecting investor confidence amidst changes. |
| 2026-05-26 09:35:43 The reported positive results for its gene therapy indicate potential growth and profitability for Eli Lilly. |
| 2026-05-26 09:35:43 The company's initiative to enter the infectious disease sector reflects an important shift in its business strategy. |
| 2026-05-26 09:35:43 Eli Lilly's plan to acquire three vaccine developers highlights its strategic investment in expanding its portfolio beyond existing products. |